Resources Contact Us Home
Immunological composition of measles virus utilizing recombinant poxvirus

Image Number 12 for United States Patent #5759841.

What is described is a recombinant poxvirus, such as vaccinia virus or canarypox virus, containing foreign DNA from Morbillivirus. In one embodiment, the foreign DNA is expressed in a host by the production of a measles virus glycoprotein. In another embodiment, the foreign DNA is expressed in a host by the production of at least two measles virus glycoproteins. What is also described is a vaccine containing the recombinant poxvirus for inducing an immunological response in a host animal inoculated with the vaccine. By the present invention, cross-protection of dogs against canine distemper is obtained by inoculating the dog with the recombinant poxvirus.

  Recently Added Patents
Subscribing to content
Communicating channel state information using predictive vector quantization
Flow cytometer method and apparatus
Fuse part in semiconductor device and method for forming the same
Antibodies to Clostridium difficile toxins
Method and a channel estimating arrangement for performing channel estimation
Radiation detector array
  Randomly Featured Patents
Access control apparatus
Palladium catalyzed carbonylation process utilizing aromatic substituted alcohols and/or aromatic substituted alkyl halides
Method and system for mobile receiver antenna architecture for handling various digital video broadcast channels
Combined bottle and cap
Lean catalyst and particulate filter control
Magnetic head used in magnetooptical recording
Molecular enhancement of extracellular matrix and methods of use
Garage screen door
Minimally-invasive portal system for performing lumbar decompression, instrumented fusion/stabilization, and the like
Floor lamp